JBIO · Company research
Jade Biosciences, Inc. Common Stock (JBIO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| how InvestingPro’s fair value flagged Jade Biosciences’ 48% decline By Investing.com - Investing.com | how InvestingPro’s fair value flagged Jade Biosciences’ 48% decline By Investing.com Investing.com | View source ↗ | Investing.com | Oct 6, 2026 | neutral | 0 | 0.6 |
| Jade Biosciences Inc (JBIO-Q) Stock Price and News - The Globe and Mail | Jade Biosciences Inc (JBIO-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 1, 2026 | neutral | 0 | 0.6 |
| Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis - Slideshow - Seeking Alpha | Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis - Slideshow Seeking Alpha | View source ↗ | Seeking Alpha | Sep 30, 2026 | neutral | 0 | 0.6 |
| Jade Biosciences (JBIO) Slips 1.6% as Shares Test Key Support at $19.97 - Long Short Pair - dars.gov.et | Jade Biosciences (JBIO) Slips 1.6% as Shares Test Key Support at $19.97 - Long Short Pair dars.gov.et | View source ↗ | dars.gov.et | Sep 1, 2026 | neutral | 0 | 0.6 |
| Jade Biosciences: Duration Is The Real Product (NASDAQ:JBIO) - Seeking Alpha | Jade Biosciences: Duration Is The Real Product (NASDAQ:JBIO) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 19, 2026 | neutral | 0 | 0.6 |
| Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market? - Yahoo Finance | Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| JBIO Forecast — Price Target — Prediction for 2027 - TradingView | JBIO Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Jade Biosciences Completes Public Offering of 11.5 Million Shares, Raising $172.5 Million for Autoimmune Disease Therapies - Quiver Quantitative | Jade Biosciences Completes Public Offering of 11.5 Million Shares, Raising $172.5 Million for Autoimmune Disease Therapies Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 5, 2026 | neutral | 0 | 0.6 |
| Why Is Jade Biosciences Stock Trading Lower On Monday? - Jade Biosciences (NASDAQ:JBIO) - Benzinga | Why Is Jade Biosciences Stock Trading Lower On Monday? - Jade Biosciences (NASDAQ:JBIO) Benzinga | View source ↗ | Benzinga | Jun 1, 2026 | neutral | 0 | 0.6 |
| Assessing Jade Biosciences (JBIO) Valuation After Recent Share Price Weakness And Longer Term Gains - Yahoo Finance | Assessing Jade Biosciences (JBIO) Valuation After Recent Share Price Weakness And Longer Term Gains Yahoo Finance | View source ↗ | Yahoo Finance | May 28, 2026 | neutral | 0 | 0.6 |
| We're Hopeful That Jade Biosciences (NASDAQ:JBIO) Will Use Its Cash Wisely - Simply Wall Street | We're Hopeful That Jade Biosciences (NASDAQ:JBIO) Will Use Its Cash Wisely Simply Wall Street | View source ↗ | Simply Wall Street | Apr 21, 2026 | neutral | 0 | 0.6 |
| Jade Biosciences: Caution Advised Before Clinical Trial Results (NASDAQ:JBIO) - Seeking Alpha | Jade Biosciences: Caution Advised Before Clinical Trial Results (NASDAQ:JBIO) Seeking Alpha | View source ↗ | Seeking Alpha | Apr 19, 2026 | neutral | 0 | 0.6 |
| Companies Like Jade Biosciences (NASDAQ:JBIO) Are In A Position To Invest In Growth - Yahoo Finance | Companies Like Jade Biosciences (NASDAQ:JBIO) Are In A Position To Invest In Growth Yahoo Finance | View source ↗ | Yahoo Finance | Mar 28, 2026 | neutral | 0 | 0.6 |
| Jade Biosciences, Inc. Common Stock (JBIO) Stock Price: Oct 8 Close $14.15 - Gotrade | Jade Biosciences, Inc. Common Stock (JBIO) Stock Price: Oct 8 Close $14.15 Gotrade | View source ↗ | Gotrade | Mar 25, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | May 6, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.